We use cookies to give you the best online experience. By using our website you agree to our use of cookies in accordance with our cookie policy. Learn more here.Close Me
A report by the WTO Unit at the Ministry of Industry & Trade expects that the new patent law will come into force shortly. The report outlined that it is expected that the new law, along with Jordan’s highly qualified work force, will encourage an influx of foreign pharmaceutical firms investing in Jordan. In response Jordanian Companies are collaborating with other foreign companies, one such example lead two small Jordanian pharmaceutical companies recently to merged and then collaborated with a foreign firm to produce hormones and insulin, for sale in the Middle Eastern markets.
The report, titled "Tackling the Challenges Facing the Jordanian Pharmaceutical Sector", stated that the TRIPs agreement, which covers all aspects of intellectual property - patents, copyrights, geographical indications, and industrial designs - has made it obligatory for member countries to enforce intellectual property rights. The new patent law will protect both process and product patents. This protection will have a major impact on the pharmaceutical industry, as firms will no longer be able to infringe on patented products and will only be able to produce pharmaceuticals with a license and by paying royalties to the patent owners.
This issue was of most concern to the pharmaceutical industry as was noted during Jordan’s negotiations for accession to the WTO. Jordan requested a transitional grace period to implement the conditions stated in order to allow Jordanian firms time to adjust. Some WTO members agreed but stipulated protection of pharmaceuticals with retroactive effect back to 1995 against a three-year grace period.
The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.
To print this article, all you need is to be registered on Mondaq.com.
Click to Login as an existing user or Register so you can print this article.
BMW had sued Grandmark, a company that is a major supplier of replacement parts, in other words vehicle parts that aren't manufactured by the vehicle manufacturers themselves but rather by independent companies, and that often cost a fraction of the price of the originals.
The Economist, in an editorial called ‘Print Me a Stradivarius’, recently questioned how 3- dimensional printing will affect IP. My reaction was a simple: Say What!
A discussion on the decision of the Indian Supreme Court to deny Novartis’s application for patent protection for an improved version of its patented Glivec drug.
The news that what’s arguably the world’s best known company, Apple, is unable to continue selling what’s arguably the world’s hottest product, IPad, under that name in China will give IP lawyers the heebie-jeebies.
A Brazilian company called Gradiente has managed to get a Brazilian trade mark registration for the mark iPhone for cell phones.
Some comments from our readers… “The articles are extremely timely and highly applicable” “I often find critical information not available elsewhere” “As in-house counsel, Mondaq’s service is of great value”
